Having negative prognostic scores in this study indicates that the expression of NPY and its receptors in cutaneous melanoma is associated with favorable survival outcomes for patients, which is in agreement with the findings from Pérez Tato and colleagues’ clinical study of NPY expression in primary cutaneous melanomas (86). Here, NPY is linked to cutaneous melanoma.